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Cell adhesion mediated by adhesion molecules is of central importance in the
maintenance of tissue homeostasis. Therefore, altered expression of adhesion molecules
leads to the development of various tissue disorders involving cell activation,
degeneration, and apoptosis. Nevertheless, it still remains unclear what initiates the
altered expression of adhesion molecules and how the subsequent pathological
cascades proceed. In this regard, cell adhesion molecule 1 (CADM1) is one of
the candidates that is involved in the development of pathological lesions; it is an
intercellular adhesion molecule that is expressed in various types of cells such as
pulmonary cells, neurons, and mast cells. Recent studies have revealed that alterations
in the transcriptional or post-transcriptional expressions of CADM1 correlate with the
pathogenesis of pulmonary diseases and allergic diseases. In this review, we specifically
focus on how CADM1 is involved in the development of pathological lesions in pulmonary
emphysema and atopic dermatitis.
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FUNCTION OF CADM1 UNDER NORMAL CONDITIONS
In the last two or three decades, a line of studies have revealed the molecular basis of cell adhesion
to neighboring cells and surrounding extracellular matrices in our body. That is, cell adhesion
is of crucial importance in human body homeostasis (Macara et al., 2014). Dedicated proteins
directly mediating cell adhesion have been revealed such as cadherins, integrins, selectins, and
immunoglobulin superfamily members; they are now called “adhesion molecules” (Coombe and
Dye, 2010).
In particular, accumulating data demonstrate the importance of cell adhesion molecule 1
(CADM1), which is an intercellular adhesion molecule that belongs to the immunoglobulin
(Ig) superfamily (Kuramochi et al., 2001). CADM1 comprises three major functional domains:
an extracellular Ig-like domain, a single transmembrane region, and a short carboxy-terminal
intracytoplasmic tail that is further composed of a protein 4.1-binding motif and a PDZ
type II domain-binding motif (Kuramochi et al., 2001). Historically, CADM1 has had several
nomenclatures such as spermatogenic immunoglobulin superfamily (SgIGSF), tumor suppressor
in lung cancer 1 (TSLC1), nectin-like molecule 2 (Necl2), and synaptic cell adhesion molecule
(SynCAM), based on its diverse functional nature in various cell lineages such as spermatogonia,
lung epithelial cells, and neurons (Watabe et al., 2003). We have previously demonstrated that
CADM1 is expressed in mast cells (Ito et al., 2003), biliary cells (Ito et al., 2007), pancreatic
endocrine cells (Koma et al., 2008), and osteoblasts (Inoue et al., 2013). In addition, CADM1 has
been shown to have several splicing isoforms; these isoforms expressed on the cell surface are
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named SP1 to SP4 based on the difference in the length of
the juxtamembranous extracellular region (Biederer, 2006). Lung
epithelial cells and mast cells exclusively express the SP4 isoform
whereas neurons express various combinations of these four
isoforms (Ito et al., 2003; Sakurai-Yageta et al., 2009; Hagiyama
et al., 2011).
In epithelia, CADM1 is located on the lateral cell membrane
and mediates neighboring cell adhesion via trans-homophilic
interaction (Koma et al., 2008; Ito et al., 2012). CADM1 directly
interacts with a spectrin-actin-binding protein DAL1 through
the intracytoplasmic protein 4.1-binding motif to promote the
formation of epithelial cell morphology (Yageta et al., 2002;
Sakurai-Yageta et al., 2009). CADM1 also interacts with a
membrane-associated guanylate kinase PALS2 through the PDZ
type II domain-binding motif; this interaction controls epithelial
cell polarity (Shingai et al., 2003; Wu et al., 2007). In mast
cells, CADM1 mediates their adhesion to fibroblasts (Ito et al.,
2003), airway smooth muscle cells (Moiseeva et al., 2013), and
neurons (Furuno et al., 2005). In particular, CADM1 plays
a central role in the direct cell-to-cell contact between mast
cells and unmyelinated C-fibers of sensory neurons through
trans-homophilical interaction to promote neurno-immune
interaction between them (Furuno et al., 2005).
PATHOGENIC ACTIONS OF CADM1 IN
PULMONARY EMPHYSEMA
Pathologically, the adhesion molecules is involved in the
development and progression of diseases and disorders such
as tumors (Demetriou and Cress, 2004), inflammatory diseases
(Macauley et al., 2014), and neurological diseases (Berezin et al.,
2014). Then, how can they be pathogenic without genetic
mutations? One of possible mechanisms is their susceptibility
to proteolysis. Since the adhesion molecules are expressed
on the cell membrane, they often undergo extra- and inter-
membraneous enzymatic cleavage; this phenomenon is termed
“ectodomain shedding” (Edwards et al., 2008). CADM1 is shed at
the extracellular domain by a disintegrin and metalloproteinase
10 (ADAM10) protease to produce a membrane-bound α
C-terminal fragment (αCTF); CADM1 is also shed by yet
unidentified proteases to produce βCTF (Nagara et al., 2012;
Mimae et al., 2014). Tobacco smoking is known to induce
an imbalanced increase in protease activity within lung alveoli
(Taraseviciene-Stewart and Voelkel, 2008). As a consequence,
lung epithelial CADM1 is shed in smokers’ lungs at high levels
to produce a substantial amount of αCTF and βCTF. Then,
αCTF enters into the lung epithelial cytoplasm, accumulates
in mitochondria, and depolarizes the mitochondrial outer
membrane potential; this process results in mitochondrial
apoptotic pathway (Mimae et al., 2014). Because the full-length
CADM1 plays an important role in the maintenance of epithelial
polarity (Sakurai-Yageta et al., 2009), an increase in CADM1
shedding with an accompanying decrease in the full-length
CADM1 induces the disruption of alveolar cell polarity and the
cell apoptosis (Yoneshige et al., 2015).
There is the third CADM1 shedding event; the truncated
products αCTF and βCTF can be further cleaved within its
transmembrane region by γ-secretase to produce free fragments
of the intracellular domain (ICD; Nagara et al., 2012). In a
similar fashion to αCTF, ICD moves into mitochondria and
induces apoptosis of lung epithelial cells (Hagiyama et al., 2015).
Through these events, CADM1 is involved in the development
and progression of pulmonary emphysema, a smoking-related
lung degenerative disease characterized by the peripheral airspace
enlargement associated with increased apoptosis of alveolar cells
(Mimae et al., 2014; Figure 1). Similarly, CADM1-mediated
pathological mechanisms have been proven in idiopathic
interstitial pneumonia by inducing the apoptosis of type 2
alveolar cells (Yoneshige et al., 2015) and type 2 diabetic pancreas
by inducing the apoptosis of insulin-secreting islet β cells (Inoue
et al., 2014).
PATHOGENIC ACTIONS OF CADM1 IN
ATOPIC DERMATITIS
We have also demonstrated pathological roles of CADM1 in
atopic dermatitis (Hagiyama et al., 2013). It has long been known
FIGURE 1 | Increased ectodomain shedding of CADM1 as a cause of
epithelial cell apoptosis. In epithelia, CADM1 is located on the lateral cell
membrane and mediates neighboring cell adhesion via trans-homophilic
binding. Under pathological conditions, ectodomain shedding of CADM1 is
induced through an imbalanced increase in protease activity such as
neutrophil elastases, macrophage matrix metalloproteinases, and/or the
inactivation of anti-protease α1-antitrypsin. CADM1 is shed at the extracellular
domain by a disintegrin and metalloproteinase 10 (ADAM10) protease to
produce a membrane-bound α C-terminal fragment (αCTF). Then, the
truncated product αCTF enters into cytoplasm, accumulates in mitochondria,
and depolarizes the mitochondrial outer membrane potential; this process
results in mitochondrial apoptotic pathway. αCTF can be further cleaved within
its transmembrane region by γ-secretase to produce free fragments of the
intracellular domain (ICD). In similar to αCTF, ICD moves into mitochondria and
induces apoptosis of lung epithelial cells. An increase in CADM1 shedding with
an accompanying decrease in the full-length CADM1 induces the disruption of
alveolar cell polarity and the cell apoptosis.
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FIGURE 2 | CADM1-mediated nerve–mast cell interaction in the atopic
dermatitis skin lesion. Dermal mast cells are observed in contact with nerve
fibers in the atopic dermatitis. These lesional mast cells express CADM1 at
higher levels than those in the normal skin, which is induced by the basic
helix-loop-helix type microphthalmia-transcription factor (MITF).
CADM1-expressing mast cells interact with neurons to secrete substance P
(SP), and the neuron-derived substance P further interacts with the cognate
receptor neurokinin 1 (NK-1) expressed on the mast cells to induce their
degranulation.
that pathological cell adhesion is observed between nerve fibers
and mast cells in atopic dermatitis lesions (Jarvikallio et al.,
2003). Here, mast cells are immune cells featured by cytoplasmic
granules containing various bioactive molecules. Their unique
characteristics is that, unlike other immune cells, they exist in the
digestive and respiratory mucosa and skin dermis at a certain cell
density under healthy conditions (Kitamura et al., 2007). Under
pathological conditions, however, the number of mast cells is
increased through the proliferation of tissue-resident mast cells
and also the recruitment from circulating myeloid progenitor
cells (Jung and Scholz, 2008).
In a mouse model of hapten-induced atopic dermatitis,
dermal mast cells were observed in contact with nerve fibers
at high frequencies (Shiohara et al., 2004). Our laser capture
microdissection-based RT-qPCT analyses revealed that the
lesional mast cells expressed CADM1 mRNA at approximately
five-fold higher levels than those in the normal skin (Hagiyama
et al., 2013). This altered CADM1 expression appears to be
induced by the basic helix-loop-helix type microphthalmia-
transcription factor (MITF), a key factor for mast cell
differentiation (Ito et al., 2003). When neurons and mast
cells are co-cultured, the kinetic strength (force-induced
dissociation rate) of mast cell adhesion to nerve fibers varies
dependently on the expression levels of CADM1 on mast
cells (Hagiyama et al., 2013). We have previously shown that
the CADM1-expressing mast cells interact with neurons to
secrete substance P and that such neuron-derived substance P
further interacts with the cognate receptor neurokinin that is
1 expressed on the mast cells to induce their degranulation
(Furuno et al., 2004, 2005). Taken together, these data suggest
that neuron-mast cell adhesion (so called “neuro-immune
interaction”) might be strengthened in atopic dermatitis through
an increased expression of CADM1 in mast cells. This
mechanism is recently highlighted as a molecular basis that
can explain why mental stress exacerbates atopic dermatitis
(Figure 2).
CONCLUDING REMARKS
As reviewed here, CADM1 is involved in the development
of pulmonary emphysema through its ectodomain shedding
in lung epithelial cells by promoting the apoptosis of lung
epithelial cells. Since apoptotic cell death is frequently observed
in various degenerative diseases, future studies may identify
the protease-mediated shedding of adhesion molecules as
a common cause for tissue degeneration. Furthermore,
an increased expression of CADM1 is involved in the
development of atopic dermatitis by promoting the neuro-
immune interaction. Recent advances in biological experimental
techniques and future studies may identify this lesion-specific
cell adhesion as a major cause of various inflammatory
diseases.
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